Sign in
4

Changes in Ownership

NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-20-036698

Chief Research Officer acquired 5,571 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Grigoriadis Dimitri E. · Chief Research Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-06-11 Exercise or conversion : show line 1 in the form +2,710 $32.99 $89,403 74,702 D
2020-06-11 Exercise or conversion : show line 2 in the form +1,812 $35.99 $65,214 76,514 D
2020-06-11 Exercise or conversion : show line 3 in the form +1,049 $43.24 $45,359 77,563 D

Table II: Derivative

3 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2020-06-11 Exercise or conversion : show line 4 in the form Incentive Stock Option −2,710 $32.99 $89,403 $32.99 2025-02-03 2,710 0 D
2020-06-11 Exercise or conversion : show line 5 in the form Incentive Stock Option −1,812 $35.99 $65,214 $35.99 2026-02-05 1,812 0 D
2020-06-11 Exercise or conversion : show line 6 in the form Incentive Stock Option −1,049 $43.24 $45,359 $43.24 2027-02-06 1,049 2,151 D
Loading xslF345X03/doc4.xml…